Serum ATIC Expression as a Novel Diagnostic and Prognostic Biomarker in Multiple Myeloma Patients.

Blood Lymphat Cancer · 2025 · PMC12409478 · PMID 40917107

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

a decreasing trendp < 0.05actually significant

Notably, serum ATIC levels in patients with MM exhibited a decreasing trend as the treatment response improved, and the Remission Group showed a marked decrease compared to the Active Disease Group (p < 0.05).

also in 29,876 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.